Remnant cholesterol and triglyceride-rich lipoproteins: what human genetics tells us about causality beyond LDL

30 August 2026 (17:30 - 17:42)

Organised by:

About the speaker

Professor Anne Tybjaerg-Hansen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail

Lp(a), aortic valve stenosis, and atherosclerosis

Doctor S. Kraler (Zurich, CH)

Presentation thumbnail

Emerging mechanisms controlling immunoinflammatory response during atherogenesis

Miss M. Depuydt (Amsterdam, NL)

Presentation thumbnail

Targeting deoxyribonucleic acid and ribonucleic acid in the context of lipid-lowering and vascular disorders

Professor N. Bouatia-Naji (Paris, FR)

Presentation thumbnail

New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein? - discussion

Access the full session

Session thumbnail

New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein?

The Event

Event poster

ESC Congress 2026

30 August 2026 17:30 CET

You may be interested in

Congress Presentation

Are triglycerides and triglyceride-rich lipoproteins still relevant?

25 August 2023

Congress Presentation

Identification of six novel susceptibility loci for dyslipidemia by longitudinal exome-wide association studies in japanese

29 August 2020

Congress Presentation

Remnant cholesterol and its role in patients with coronary atherosclerosis evaluated by coronary CT

13 December 2025

Webinar

Biomarkers of clinical utility in cardiovascular disease

17 December 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources